🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Check out this new method for peptide sequencing via DNA barcoding by ⁦The Soh Lab @ Stanford⁩ and coworkers ⁦Stanford Engineering⁩! Nice use of #bioorthogonal chemistry 😃 Peptide sequencing via reverse translation of peptides into DNA | bioRxiv biorxiv.org/content/10.110…

🎉 Today, we celebrate 2⃣ years of scouts, seed grants, and innovative science!🧬 @HypothesisFund CEO & Founder, David Sanford, reflects upon our milestones and share learnings important for the years ahead. Here's to exciting and impactful frontiers! linkedin.com/pulse/hypothes…

Excited and honored to receive support from @OnoPharmaFound! Awesome to join this community of amazing chemical biologists.

Membrane curvature promotes ER-PM contacts in cardiomyocytes. Excited to share our work published in Nature Cell Biology today. Congratulations to Yang and the team! nature.com/articles/s4155…

.Steven Banik,Christine Isadora Ng & team devised a new class of molecules called TRAMs to convince natural shuttles to bring misplaced, disease-related proteins back to their homes. This could lead to new treatments for cancers and neurodegeneration stanford.io/3XRzVY9

Thrilled to share our work on novo protein LYTAC(pLYTAC)/EndoTag in @nature! Using de novo protein design, we created endocytosis triggering binding proteins (EndoTags) to degrade extracellular targets and amplify receptor signaling. nature.com/articles/s4158…

Thanks for the invitation @georg_e_winter! Amazing to visit CeMM and hear about exciting work happening!

🚨NEW PUBLICATION ALERT🚨: In a paper out today in Science Magazine we describe a way to build synthetic phosphorylation circuits with customizable sense-and-response functions in human cells. Check it out at science.org/doi/10.1126/sc…. 🧵1/n

Landmark preprint from Lycia Therapeutics, first example of catalytic #LYTAC (cataLYTAC) design for potent and durable extracellular #TPD. Demonstrated with design of LYTAC that clears IgE in NHPs, excited to see this technology advance to the clinic 🎉

Congratulations to Alessandra Salerno 👩‍🔬 from Centre for Targeted Protein Degradation and Christine Isadora Ng from Stanford University who have been selected as awardees of our conference travel scholarships to attend the Keystone Proximity-Based Therapeutics conference!

Incredibly proud of Christine Isadora Ng for defending her PhD work today (the first Banik lab PhD!). So lucky to have been a part of her journey!